INTRA-CELLULAR THERAPIES INC (ITCI)
Institutional ownership reported to the SEC as of Q2 2026, across 31 quarters.
1
Reporting holders
$2.5K
Reported value
0.0%
Held as options
+0
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| HUNTINGTON NATIONAL BANK | $2.5K | 1 | 0.00% | 18q | HELD |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 1 | $2.5K | 1 | 0 | 0 | 0 | 0.0% |
| Q1 2026 | 1 | $2.5K | 1 | 0 | 0 | 0 | 0.0% |
| Q4 2025 | 1 | $2.5K | 1 | 0 | 0 | 0 | 0.0% |
| Q3 2025 | 1 | $2.5K | 1 | 0 | 0 | 0 | 0.0% |
| Q2 2025 | 4 | $72.6K | 52,839 | 0 | 0 | 2 | 0.0% |
| Q1 2025 | 374 | $13.8B | 101,766,013 | 151 | 79 | 109 | 4.5% |
| Q4 2024 | 362 | $7.8B | 93,372,603 | 48 | 112 | 120 | 0.4% |
| Q3 2024 | 324 | $7.3B | 98,443,356 | 42 | 117 | 112 | 0.6% |
| Q2 2024 | 332 | $6.6B | 95,633,718 | 61 | 124 | 111 | 0.9% |
| Q1 2024 | 313 | $6.5B | 88,298,820 | 48 | 110 | 102 | 6.2% |
| Q4 2023 | 296 | $6.4B | 88,298,972 | 49 | 95 | 96 | 1.3% |
| Q3 2023 | 263 | $4.3B | 82,732,856 | 34 | 101 | 80 | 0.6% |
| Q2 2023 | 251 | $5.0B | 79,342,443 | 40 | 98 | 66 | 0.5% |
| Q1 2023 | 238 | $4.9B | 90,685,322 | 31 | 90 | 70 | 1.2% |
| Q4 2022 | 228 | $3.8B | 71,882,417 | 33 | 70 | 71 | 0.9% |
| Q3 2022 | 270 | $3.9B | 83,839,413 | 42 | 97 | 79 | 1.0% |
| Q2 2022 | 267 | $4.7B | 81,479,425 | 46 | 91 | 88 | 1.2% |
| Q1 2022 | 245 | $5.0B | 80,816,832 | 66 | 87 | 63 | 1.0% |
| Q4 2021 | 212 | $3.7B | 69,176,274 | 42 | 53 | 62 | 3.1% |
| Q3 2021 | 180 | $2.6B | 68,588,544 | 18 | 71 | 47 | 1.5% |
| Q2 2021 | 188 | $2.8B | 67,022,908 | 35 | 56 | 61 | 1.8% |
| Q1 2021 | 167 | $2.3B | 67,974,937 | 22 | 46 | 65 | 1.7% |
| Q4 2020 | 179 | $2.3B | 68,664,257 | 33 | 60 | 49 | 3.1% |
| Q3 2020 | 176 | $1.7B | 63,781,760 | 47 | 70 | 39 | 4.1% |
| Q2 2020 | 155 | $1.4B | 48,766,395 | 38 | 57 | 33 | 9.6% |
| Q1 2020 | 141 | $773.4M | 48,046,842 | 29 | 63 | 28 | 2.4% |
| Q4 2019 | 144 | $2.1B | 38,876,000 | 26 | 36 | 49 | 37.7% |
| Q3 2019 | 135 | $341.7M | 40,174,948 | 25 | 42 | 36 | 12.2% |
| Q2 2019 | 140 | $609.5M | 38,735,984 | 24 | 45 | 34 | 17.5% |
| Q1 2019 | 136 | $516.1M | 38,438,625 | 13 | 51 | 29 | 9.1% |
| Q4 2018 | 133 | $498.9M | 38,438,488 | 3 | 1 | 2 | 12.2% |